Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fil Manuguid

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Future Oncology (London, England)|April 21, 2021
Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western EuropeMadhusudan Kabra, Luana Margotto, Fil Manuguid
Nature Reviews. Drug Discovery|March 2, 2011
Eribulin mesylateTimothy K Huyck, William Gradishar, Fil Manuguid, et al.
Nature Reviews. Drug Discovery|August 2, 2011
Abiraterone acetateChristopher J Logothetis, Eleni Efstathiou, Fil Manuguid, et al.
Future Oncology (London, England)|November 17, 2023
Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4 + UK perspectiveMagdalena Ruiz, Kriti Jindal, Vicky Casey, et al.
Future Oncology (London, England)|May 4, 2023
Treatment patterns and outcomes in patients with metastatic synovial sarcoma in France, Germany, Italy, Spain and the UKNashita Patel, Shibani Pokras, Jane Ferma, et al.
Future Oncology (London, England)|January 19, 2021
Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countriesGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
Future Oncology (London, England)|January 19, 2021
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology databaseGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
Thoracic Cancer|August 18, 2023
Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5Alexander Slowley, Kelesitse Phiri, Jasjit K Multani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|April 21, 2021
Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western EuropeMadhusudan Kabra, Luana Margotto, Fil Manuguid
Nature Reviews. Drug Discovery|March 2, 2011
Eribulin mesylateTimothy K Huyck, William Gradishar, Fil Manuguid, et al.
Nature Reviews. Drug Discovery|August 2, 2011
Abiraterone acetateChristopher J Logothetis, Eleni Efstathiou, Fil Manuguid, et al.
Future Oncology (London, England)|November 17, 2023
Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4 + UK perspectiveMagdalena Ruiz, Kriti Jindal, Vicky Casey, et al.
Future Oncology (London, England)|May 4, 2023
Treatment patterns and outcomes in patients with metastatic synovial sarcoma in France, Germany, Italy, Spain and the UKNashita Patel, Shibani Pokras, Jane Ferma, et al.
Future Oncology (London, England)|January 19, 2021
Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countriesGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
Future Oncology (London, England)|January 19, 2021
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology databaseGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
Thoracic Cancer|August 18, 2023
Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5Alexander Slowley, Kelesitse Phiri, Jasjit K Multani, et al.
Pageof 1